PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

🧠 Clinical library

Clinical Specialty Index

453 articles indexed across 24 specialties, each reviewed by a licensed pharmacist before publication.

Showing 32 from 1 topic.Sort: Newest | Oldest
LAAC Noninferior to DOACs in High-Risk Atrial Fibrillation
Analysis Anticoagulation / Hematology Hypothesis-generating Grade: Moderate
Osmancik P, Herman D, Neuzil P, et al.
Jun 30, 2020 · Published in: Journal of the American College of Cardiology
Also in Cardiology

LAAC proves noninferior to DOACs in high-risk AF stroke prevention.

ANNEXA-4: Andexanet Reverses Factor Xa Inhibitors Amid Thrombotic Risk
Analysis Anticoagulation / Hematology Hypothesis-generating Grade: Low
Connolly SJ, Crowther M, Eikelboom JW, et al.
Feb 7, 2019 · Published in: New England Journal of Medicine

Andexanet alfa reduces factor Xa activity by 92% in bleeding emergencies.